共 9 条
[1]
Transplantation[P]. 英国专利:GB9904281D0,1999-04-21
[2]
Influence of common variants in the pharmacokinetic genes (OATP-C, UGT1A1,and MRP2 ) on serum bilirubin levels in healthy subjects. Ieiri I,Suzuki H,K imura M,et al. Hepatology Research . 2004
[3]
Novel single nucleotide polymorphisms of organic cation transporter 1 ( SLC22A1 )affecting transport functions. Sakata T,AnzaiN,ShinHJ,et al. Biochemical and Biophysical Research Communications . 2004
[4]
Linkage disequilibrium and haplotype architecture for two ABC transporter genes(ABCC1 and ABCG2 ) in Chinese population: implications for pharmacogenom ic association studies. W ang H,Hao B,Zhou K,et al. Annals of Human Genetics . 2004
[5]
Variable expression of P-glycoprotein in the human placenta and its association with mutations of the multidrug resistance 1 gene(MDR1, ABCB1 ). H itzlM,Schaeffeler E,Hocher B,et al. Pharmacogenetics . 2004
[6]
The effect of CYP3A5 and MDR1 (ABCB1 ) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients. Haufroid V,MouradM,Van Kerckhove V,et al. Pharmacogenetics . 2004
[7]
A variant 2677A allele of the MDR1 gene affects fexofenadine disposition. Y i SY,Hong KS,Lim HS,et al. C lin Pharmacol Ther . 2004
[8]
Genetic polymorphisms in the multidrug resistance-associated protein 3 ( ABCC3,MRP3 ) gene and relationship to its mRNA and protein expression in human liver. Lang T,H itzlM,Burk O,et al. Pharmacogenetics . 2004
[9]
Modulation of multidrug resistance P-glycoprotein 1 (ABCB1 ) expression in human heart by hereditary polymorphisms. MeissnerK,Jedlitschky G,Meyer SH,et al. Pharmacogenetics . 2004